Stay tuned and follow the latest
developments and news in Molecular Oncology.
Nikos Tsoulos, CEO of Genekor I.A.E., gave an interview to THE DOCTOR magazine on the importance of genetic testing in relatives of people who have been diagnosed with breast and […]
Read More
The study by the Genekor Scientific Team on “ The study by the Genekor Scientific Team on “Polygenic Risk Score in a cohort of 105 Breast Cancer patients previously tested […]
Read More
More than 7,000 rare diseases that affect more than 300,000,000 people around the world have been identified in recent years. This fact causes the need to use particularly innovative diagnostic […]
Read MoreAnother important study by the Genekor Scientific Team on “Next Generation Sequencing (NGS) for the identification of PARP inhibitors’ predictive biomarkers” was presented by Dr. Floros Ir. Theofanis (Oncologist Pathologist, […]
Read More
The study by the Genekor Scientific Team on “Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes” was presented at ESMO CONGRESS […]
Read More
Cardiomyopathies are “really common” and affected one person in every 250 around the world, said Prof Hugh Watkins, from the University of Oxford and lead investigator of the CureHeart project. […]
Read More
A recent study showed that only 14% of men and 30% of women regularly put sunscreen on their face and other exposed body parts before going out for more than […]
Read More
Genekor Medical S.A. in the context of social responsibility and with the aim of offering quality medical diagnostic services to all children in need, provides the Children’s Hospital “Agia Sophia”, […]
Read More
RediScore® is a test developed to predict the presence of HRD through the analysis of the tumor’s genomic instability. RediScore® is a test developed to predict the presence of HRD […]
Read More